Journal for ImmunoTherapy of Cancer (Nov 2023)
700 A phase II trial of MOnaliZumab plus durvAlumab plus platinum-based chemotheRapy for first-line treatment of extensive stage small cell lung cancer (MOZART): A Hoosier Cancer Research Network study
Abstract
No abstracts available.